Table 4.

Overview of principal BLVR-Coil Studies

Author	Year	n	Follow-up, M	Δ FEV1	Δ RV	Δ 6MWT	Δ SGRQ
Slebos et al. [24]	2012	16	6	+14.9%	−11.4%	+84.4 m	−14.9
Shah et al. [25]	2013	23	3	+14.1%	−0.51 L	+51.1 m	−8.6
Klooster et al. [26]	2014	10	6	+0.11 L	−22.0%	+61.0 m	−15.0
Deslee et al. [27]	2014	34	12	+16.0%	−13.75%	+51.4 m	−11.1
Hartman et al. [28]	2014	35	12	+0.20 L	−21%	+31.0 m	−4.2
		27	24	− 0.05 L	−10%	−12.0 m	−8.0
		22	36	− 0.04 L	−2%	−31.5 m	−7.2
Zoumot et al. [29]	2015	35	12	+ 8.9%	−0.32 L	+34.1 m	−6.1
Deslee et al. [30]	2016	50	12	+ 0.09 L	−0.52 L	+9%	−11.1
Sciurba et al. [31]	2016	158	12	+ 7.0%	−0.31 L	+14.6 m	−8.9
Gülsen et al. [32]	2017	40	6	+0.15 L	−14.5%	+48.0 m	−10.4
Simon et al. [33]	2018	33	3	+0.10 L	−0.44 L	+48.0 m	*
Overview of Complications
Author	Year	n	Follow-up, M	Pnx	COPD Exc.	Pneumonia	Death
Slebos et al. [24]	2012	16	6	0	87.0%	18.7%	0
Shah et al. [25]	2013	23	3	8.6%	17.0%	0	0
Klooster et al. [26]	2014	10	6	10%	70.0%	0	0
Deslee et al. [27]	2014	34	12	11.6%	33.0%	23.3%	0
Hartman et al. [28]	2014	35	12	6.0%	51.0%	46.0%	3%
		27	24	0	37.0%	7.0%	8%
		22	36	0	36.0%	5.0%	6%
Zoumot et al. [29]	2015	84	12	9.6%	10.8%	2.4%	-
Deslee et al. [30]	2016	50	12	2.0%	26.0%	18.0%	8%
Sciurba et al. [31]	2016	158	12	9.7%	27.7%	20.0%	6.5%
Gülsen et al. [32]	2017	40	6	0	41.4%	17.0%	2%
Simon et al. [33]	2018	33	3	0	46.3%	5.6%	0

n: patient population; COPD: Chronic obstructive pulmonary disease; FEV₁: forced expiration volume in the 1 s; Δ: change; M: month; SGRQ: St George’s Respiratory Questionnaire total score